Cited by 307Neuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatmentsMemory and Neural Mechanisms

Microtubule-associated protein tau is essential for long-term depression in the hippocampus

Open access
Kimura, Tetsuya, Whitcomb, Daniel J., Jo, Jihoon, Regan, Philip, Piers, Thomas, Heo, Seonghoo, Brown, Christopher, Hashikawa, Tsutomu +7 more·2014·Philosophical Transactions of the Royal Society B: Biological Sciences

Abstract

The microtubule-associated protein tau is a principal component of neurofibrillary tangles, and has been identified as a key molecule in Alzheimer's disease and other tauopathies. However, it is unknown how a protein that is primarily located in axons is involved in a disease that is believed to have a synaptic origin. To investigate a possible synaptic function of tau, we studied synaptic plasticity in the hippocampus and found a selective deficit in long-term depression (LTD) in tau knockout mice in vivo and in vitro , an effect that was replicated by RNAi knockdown of tau in vitro . We found that the induction of LTD is associated with the glycogen synthase kinase-3-mediated phosphorylation of tau. These observations demonstrate that tau has a critical physiological function in LTD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1098/rstb.2013.0144

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tau-mediated neurodegeneration arises from multiple pathological mechanisms including loss of normal function, gain of toxic function, aggregation, and mislocalization.

    “Tau-mediated neurodegeneration arises from multiple pathological mechanisms, including loss of normal function [37–42], gain of toxic function [43–46], aggregation [44, 47–49], and mislocalization [50–52].”

    From Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease (2026) · cites this paper as [41]

    The Discussion (page unavailable) links dysregulation of tau’s normal function to neuronal pathology and describes hyperphosphorylation, neurofibrillary tangles, and missorting into somatodendrites. The Introduction (page unavailable) also associates tau accumulation with synapse and neuron loss. The paper does not establish gain of toxic function as a distinct mechanism, so it does not support the full four-part claim. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • The literature has established a role for tau in regulating glutamatergic synaptic function, where it interacts with Fyn, NMDARs, PSD-95, and SynGAP1.

    “The literature has established a role for tau in regulating glutamatergic synaptic function, where it interacts with Fyn, NMDARs, PSD-95, and SynGAP1 [41, 77, 105].”

    From Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease (2026) · cites this paper as [41]

    The Discussion reports that tau is required for hippocampal long-term depression, supporting a role in synaptic function. The Results place tau in a PSD-95-rich fraction, and the Discussion says NMDAR activation can affect its localization, but neither establishes direct interaction with PSD-95 or NMDARs. The searched passages do not support interactions with Fyn or SynGAP1. Page numbers were not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Post-synaptic Tau is crucial for LTD.

    “Post-synaptic Tau has been demonstrated to be crucial for LTD [73].”

    From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [73]

    The Results show that tau knockdown in CA1 neurons blocks LTD, and the section ‘Tau is found in the postsynaptic compartment’ detects tau in dendritic spines. But that section says postsynaptic tau ‘could, in principle, function directly in LTD’; it does not demonstrate that the postsynaptic fraction specifically is crucial. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Dendritic tau may regulate synaptic plasticity; synaptic activity can recruit tau to postsynaptic densities, and tau deletion in various mouse models shows deficits in LTP or LTD.

    “Dendritic tau may also play a role in regulating synaptic plasticity, as synaptic activity can recruit tau to the postsynaptic densities, where tau deletion in various mouse models show deficits either in LTP or LTD [129, 131, 132].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 41 · Cited by 307

Authors
Kimura, T., Whitcomb, D. J., Jo, J., Regan, P., Piers, T., Heo, S., Brown, C., Hashikawa, T., Murayama, M., Seok, H., Sotiropoulos, I., Kim, E., Collingridge, G. L., Takashima, A., & Cho, K.
Affiliations
  • Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (JP)
  • University of Bristol (GB)
  • Chonnam National University Hospital (KR)
  • RIKEN Center for Brain Science (JP)
  • Korea Advanced Institute of Science and Technology (KR)
  • Seoul National University (KR)
Corresponding author
  • Takashima, Akihiko
  • Cho, Kwangwook
Venue
Philosophical Transactions of the Royal Society B: Biological Sciences
Published
2014-01-05
Volume
369
Issue
1633
Pages
20130144
ISSN
  • 0962-8436 (ISSN-L)
  • 1471-2970
OpenAlex
W2096361230
Cited by
307
References
41
Citations by year
2026: 18 · 2025: 22 · 2024: 18 · 2023: 20 · 2022: 31 · 2021: 35 · 2020: 34 · 2019: 20 · 2018: 34 · 2017: 28 · 2016: 15 · 2015: 19 · 2014: 10 · 2013: 3
FWCI
7.69
Type
journal article
Language
en
Open access
Locations
  • Philosophical Transactions of the Royal Society B Biological Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
  • Bristol Research (University of Bristol) (submittedVersion)
Funders
  • Wellcome Trust (089703)
  • Royal Society
  • Great Britain Sasakawa Foundation
  • National Center for Geriatrics and Gerontology
  • Universidade do Minho
  • Medical Research Council (MR/K023098/1, MC_G1000734)
  • Biotechnology and Biological Sciences Research Council (BB/G003963/1)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords
tau protein, long-term depression, hippocampus, synaptic plasticity, glycogen synthase kinase-3, tau phosphorylation, tau knockout mice, RNAi knockdown, Alzheimer's disease, tauopathy, neurofibrillary tangles
MeSH terms
Animals, Hippocampus, Immunohistochemistry, Male, Mice, Inbred C57BL, Microscopy, Electron, Phosphorylation, Subcellular Fractions, Synapses, Blotting, Western, tau Proteins, Rats, Wistar, Mice, Knockout, Tauopathies, RNA Interference, Long-Term Synaptic Depression, Glycogen Synthase Kinase 3, Microdissection, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review